BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20846399)

  • 1. Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.
    Usanova S; Piée-Staffa A; Sied U; Thomale J; Schneider A; Kaina B; Köberle B
    Mol Cancer; 2010 Sep; 9():248. PubMed ID: 20846399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition.
    Cavallo F; Graziani G; Antinozzi C; Feldman DR; Houldsworth J; Bosl GJ; Chaganti RS; Moynahan ME; Jasin M; Barchi M
    PLoS One; 2012; 7(12):e51563. PubMed ID: 23251575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.
    Arora S; Kothandapani A; Tillison K; Kalman-Maltese V; Patrick SM
    DNA Repair (Amst); 2010 Jul; 9(7):745-53. PubMed ID: 20418188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin.
    De Silva IU; McHugh PJ; Clingen PH; Hartley JA
    Nucleic Acids Res; 2002 Sep; 30(17):3848-56. PubMed ID: 12202770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
    Bergstralh DT; Sekelsky J
    Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.
    Bhagwat N; Olsen AL; Wang AT; Hanada K; Stuckert P; Kanaar R; D'Andrea A; Niedernhofer LJ; McHugh PJ
    Mol Cell Biol; 2009 Dec; 29(24):6427-37. PubMed ID: 19805513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivo.
    Köberle B; Ditz C; Kausch I; Wollenberg B; Ferris RL; Albers AE
    Int J Oncol; 2010 May; 36(5):1277-84. PubMed ID: 20372803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance.
    McNeil EM; Astell KR; Ritchie AM; Shave S; Houston DR; Bakrania P; Jones HM; Khurana P; Wallace C; Chapman T; Wear MA; Walkinshaw MD; Saxty B; Melton DW
    DNA Repair (Amst); 2015 Jul; 31():19-28. PubMed ID: 25956741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Perspectives of ERCC1 in Bladder Cancer.
    Koutsoukos K; Andrikopoulou A; Dedes N; Zagouri F; Bamias A; Dimopoulos MA
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers.
    Mesquita KA; Alabdullah M; Griffin M; Toss MS; Fatah TMAA; Alblihy A; Moseley P; Chan SYT; Rakha EA; Madhusudan S
    Gynecol Oncol; 2019 May; 153(2):416-424. PubMed ID: 30797591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks.
    Abdullah UB; McGouran JF; Brolih S; Ptchelkine D; El-Sagheer AH; Brown T; McHugh PJ
    EMBO J; 2017 Jul; 36(14):2047-2060. PubMed ID: 28607004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines.
    Welsh C; Day R; McGurk C; Masters JR; Wood RD; Köberle B
    Int J Cancer; 2004 Jun; 110(3):352-61. PubMed ID: 15095299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
    Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
    BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks.
    Niedernhofer LJ; Odijk H; Budzowska M; van Drunen E; Maas A; Theil AF; de Wit J; Jaspers NG; Beverloo HB; Hoeijmakers JH; Kanaar R
    Mol Cell Biol; 2004 Jul; 24(13):5776-87. PubMed ID: 15199134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours.
    Köberle B; Masters JR; Hartley JA; Wood RD
    Curr Biol; 1999 Mar; 9(5):273-6. PubMed ID: 10074455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
    Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
    Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.
    Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD
    J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours.
    Mendoza J; Martínez J; Hernández C; Pérez-Montiel D; Castro C; Fabián-Morales E; Santibáñez M; González-Barrios R; Díaz-Chávez J; Andonegui MA; Reynoso N; Oñate LF; Jiménez MA; Núñez M; Dyer R; Herrera LA
    Br J Cancer; 2013 Jul; 109(1):68-75. PubMed ID: 23807173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong apoptotic response of testis tumor cells following cisplatin treatment.
    Köberle B; Usanova S; Piee-Staffa A; Heinicke U; Clauss P; Brozovic A; Kaina B
    Int Urol Nephrol; 2024 Mar; 56(3):1007-1017. PubMed ID: 37891379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair.
    Zhang H; Chen Z; Ye Y; Ye Z; Cao D; Xiong Y; Srivastava M; Feng X; Tang M; Wang C; Tainer JA; Chen J
    Nucleic Acids Res; 2019 Nov; 47(19):10181-10201. PubMed ID: 31495888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.